Adventist Health System/ West
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed October 21, 2025), Adventist Health System/ West reported 8 stock positions worth $613.9 million. Its top holding was Vanguard S&P 500 ETF (VOO) at 48.9% of the portfolio, followed by Vanguard Ftse Developed ETF (VEA, 11.0%) and iShares Core S&P Total U.S. (ITOT, 10.9%). Compared with Q2 2025, it opened 2 new positions, sold out of 2 and reduced 2. The biggest buy was a new position in iShares Core S&P Total U.S. (ITOT) and the biggest sale an exit from iShares Core S&P 500 ETF (IVV).
- Most Recent 13F
- Q2 2026
- Location
- Roseville, CA
- CIK
- 0001802516
- Portfolio Value
- $613.9M (Q3 2025)
- SEC Filing
- 0001172661-25-004348 ↗ filed Oct 21, 2025
Holdings Value
Holdings 8 stocks · $613.9M
| VOO Vanguard S&P 500 ETF | 48.93% | 490,500 | $300.4M | No change |
| VEA Vanguard Ftse Developed ETF | 11.04% | 1,131,440 | $67.8M | No change |
| ITOT iShares Core S&P Total U.S. | 10.92% | 460,365 | $67.1M | New |
| VONV Vanguard Russell 1000 Value | 10.09% | 692,800 | $61.9M | No change |
| VTIP Vanguard Short-Term Tips | 6.32% | 766,010 | $38.8M | No change |
| IXUS iShares Core Intl Stock ETF | 6.22% | 462,368 | $38.2M | New |
| VOT Vngrd Mrngstr MC GRW ETF-Usd | 4.63% | 96,768 | $28.4M | Reduce -26.2% |
| VBK Van Morst SML-Cap Gro-Usd Inc. | 1.85% | 38,149 | $11.4M | Reduce -31.5% |
Portfolio Sells Q2 2025 → Q3 2025
Portfolio Buys Q2 2025 → Q3 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 12 | $638.1M | IVV, VEA, VONV, IXUS, ITOT |
| Q1 2026 | 13 | $563.9M | IVV, VEA, VONV, IXUS, ITOT |
| Q4 2025 | 8 | $595.0M | IVV, VEA, VONV, ITOT, VTIP |
| Q3 2025 | 8 | $613.9M | VOO, VEA, ITOT, VONV, VTIP |
| Q2 2025 | 8 | $673.3M | VOO, IVV, VEA, VONV, EMXC |
| Q1 2025 | 8 | $633.7M | VOO, IVV, IEMG, VEA, VONV |
| Q4 2024 | 8 | $646.5M | VOO, IVV, VONV, IEMG, VEA |
| Q3 2024 | 7 | $650.2M | IVV, IEMG, VEA, VONV, VTIP |
| Q2 2024 | 7 | $615.9M | IVV, IEMG, VEA, VONV, VTIP |
| Q1 2024 | 5 | $556.2M | IVV, IEFA, IEMG, VONV, VTIP |